These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7498223)

  • 1. Is planar thallium-201/fluorine-18 fluorodeoxyglucose imaging a reasonable clinical alternative to positron emission tomographic myocardial viability scanning?
    Kalff V; Berlangieri SU; Van Every B; Rowe JL; Lambrecht RM; Tochon-Danguy HJ; Egan GF; McKay WJ; Kelly MJ
    Eur J Nucl Med; 1995 Jul; 22(7):625-32. PubMed ID: 7498223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
    Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.
    Dilsizian V; Perrone-Filardi P; Arrighi JA; Bacharach SL; Quyyumi AA; Freedman NM; Bonow RO
    Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial viability assessed with fluorodeoxyglucose and PET in patients with Q wave myocardial infarction receiving thrombolysis: relationship to coronary anatomy and ventricular function.
    Fragasso G; Chierchia SL; Rossetti E; Sciammarella MG; Conversano A; Lucignani G; Landoni C; Calori G; Margonato A; Fazio F
    Nucl Med Commun; 1997 Mar; 18(3):191-9. PubMed ID: 9106772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
    Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
    J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative planar imaging of glucose metabolic activity in myocardial segments with exercise thallium-201 perfusion defects in patients with myocardial infarction: comparison with late (24-hour) redistribution thallium imaging for detection of reversible ischemia.
    Williams KA; Taillon LA; Stark VJ
    Am Heart J; 1992 Aug; 124(2):294-304. PubMed ID: 1636573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
    Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
    Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Planar cardiac F-18 fluorodeoxyglucose imaging with a conventional gamma camera.
    Kalff V; Van Every B; Lambrecht RM; Rowe JL; Barton HJ; Leaney P; Jamieson CR; Kelly MJ
    Med J Aust; 1994 Oct; 161(7):413-7. PubMed ID: 7935094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of assessing regional myocardial uptake of 18F-fluorodeoxyglucose using single photon emission computed tomography.
    Bax JJ; Visser FC; van Lingen A; Huitink JM; Kamp O; van Leeuwen GR; Visser GW; Teule GJ; Visser CA
    Eur Heart J; 1993 Dec; 14(12):1675-82. PubMed ID: 8131767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of thallium-201 single-photon emission tomography after rest injection and fluorodeoxyglucose positron emission tomography for assessment of myocardial viability in patients with chronic coronary artery disease.
    Altehoefer C; vom Dahl J; Buell U; Uebis R; Kleinhans E; Hanrath P
    Eur J Nucl Med; 1994 Jan; 21(1):37-45. PubMed ID: 8088284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects.
    Brunken RC; Mody FV; Hawkins RA; Nienaber C; Phelps ME; Schelbert HR
    Circulation; 1992 Nov; 86(5):1357-69. PubMed ID: 1423947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between reverse redistribution on planar thallium scintigraphy and regional myocardial viability: a correlative PET study.
    Soufer R; Dey HM; Lawson AJ; Wackers FJ; Zaret BL
    J Nucl Med; 1995 Feb; 36(2):180-7. PubMed ID: 7830110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography.
    Stoll HP; Hellwig N; Alexander C; Ozbek C; Schieffer H; Oberhausen E
    Eur J Nucl Med; 1994 Oct; 21(10):1085-93. PubMed ID: 7828618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy.
    Di Carli MF; Asgarzadie F; Schelbert HR; Brunken RC; Laks H; Phelps ME; Maddahi J
    Circulation; 1995 Dec; 92(12):3436-44. PubMed ID: 8521565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability.
    Burt RW; Perkins OW; Oppenheim BE; Schauwecker DS; Stein L; Wellman HN; Witt RM
    J Nucl Med; 1995 Feb; 36(2):176-9. PubMed ID: 7830109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
    Brunken RC; Mody FV; Hawkins RA; Nienaber CA; Phelps ME; Schelbert HR
    Herz; 1994 Feb; 19(1):28-41. PubMed ID: 8150412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of myocardial viability by dual-head coincidence gamma camera fluorine-18 fluorodeoxyglucose positron emission tomography with and without non-uniform attenuation correction.
    Nowak B; Zimny M; Schwarz ER; Kaiser HJ; Schaefer W; Reinartz P; vom Dahl J; Buell U
    Eur J Nucl Med; 2000 Oct; 27(10):1501-8. PubMed ID: 11083539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Course of impaired left ventricular function after acute myocardial infarction predicted with planar thallium-201 chloride and F18-fluorodeoxyglucose imaging.
    Huitink JM; Visser FC; Bax JJ; van Lingen A; Visser CA
    Int J Cardiol; 1996 Dec; 57(3):271-81. PubMed ID: 9024916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction.
    Di Carli MF; Asgarzadie F; Schelbert HR; Brunken RC; Rokhsar S; Maddahi J
    J Nucl Cardiol; 1998; 5(6):558-66. PubMed ID: 9869477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic myocardial viability assessment with iodine 123-16-iodo-3-methylhexadecanoic acid in recent myocardial infarction: comparison with thallium-201 and fluorine-18 fluorodeoxyglucose.
    Vanzetto G; Janier M; Fagret D; Cinotti L; André-Fouet X; Comet M; Machecourt J
    Eur J Nucl Med; 1997 Feb; 24(2):170-8. PubMed ID: 9021114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.